DNA 定序市場規模、佔有率、成長分析、按產品和服務、按技術、按工作流程、按應用、按最終用途、按地區 - 行業預測，2024-2031 年

2022年全球DNA定序市場規模估值為105億美元，從2023年的122.9億美元成長到2031年的440億美元，在預測期（2024-2031年）複合年成長率為17.12%，預計還將成長。

在下一代和全基因組分析技術快速進步的推動下，美國DNA 定序市場預計將出現強勁成長。 Illumina 的 NGS 等創新透過平行處理能力顯著提高定序通量和速度，從而實現了多個 DNA 片段的同時分析，從而徹底改變了基因組學。這些資料處理速度使研究人員和醫療保健專業人員能夠有效地提取診斷和個人化醫療的關鍵遺傳見解。為了展示這一趨勢，Illumina 於 2023 年 3 月推出了雲端基礎的Connected Insights 計劃，以簡化臨床 NGS資料處理。隨著人們對基因組研究和個人化醫療的興趣日益濃厚，DNA 定序已成為醫療保健領域的重要工具，為診斷、治療策略和疾病預防方面的有希望的進步鋪平了道路。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究
• 客戶和購買標準分析

DNA 定序市場規模：依產品/服務及複合年成長率（2024-2031）

• 市場概況
• 消耗品
• 裝置
• 服務

DNA 定序市場規模：依技術及複合年成長率（2024-2031）

• 市場概況
• 桑格序列
• 次世代定序
  • 全基因組定序（WGS）
  • 全EXOME定序 (WES)
  • 標靶定序和定序
• 第三代定序
  • 單分子即時定序（SMRT）
  • 奈米孔定序

DNA 定序市場規模：依工作流程及複合年成長率（2024-2031）

• 市場概況
• 預測定序
• 定序
• 資料分析

DNA 定序市場規模：依應用和複合年成長率（2024-2031）

• 市場概況
• 腫瘤學
• 生殖健康
• 臨床研究
• 農業基因組學與法醫學
• HLA型檢測/免疫系統監測
• 總體基因體學、流行病學、藥物開發
• 消費者基因體學
• 其他

DNA 定序市場規模：依最終用途及複合年成長率（2024-2031）

• 市場概況
• 學術研究
• 臨床研究
• 醫院/診所
• 製藥和生物技術公司
• 其他用戶

DNA 定序市場規模：按地區和複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Illumina, Inc.
• Thermo Fisher Scientific
• Pacific Biosciences（PacBio）
• Oxford Nanopore Technologies
• Qiagen
• Agilent Technologies
• Bio-Rad Laboratories
• PerkinElmer
• Element Biosciences
• MGI（BGI Group）
• Genewiz
• Macrogen
• OncoDNA
• Hamilton Thorne
• DNASTAR
• Eurofins GATC Biotech
• Roche Diagnostics
• Wasatch BioLabs
• Integrated DNA Technologies（IDT）
• Genomatic AG

結論和建議

Global DNA Sequencing Market size was valued at USD 10.5 billion in 2022 and is poised to grow from USD 12.29 billion in 2023 to USD 44 billion by 2031, growing at a CAGR of 17.12% in the forecast period (2024-2031).

The US DNA sequencing market is set for robust growth, fueled by rapid advancements in Next-Generation and Whole-Genome Sequencing technologies. Innovations like Illumina's NGS have revolutionized genomics by significantly enhancing sequencing throughput and speed through parallel processing capabilities, enabling the analysis of multiple DNA segments simultaneously. This acceleration in data processing empowers researchers and healthcare professionals to extract critical genetic insights for diagnostics and personalized medicine effectively. Illustrating this trend, Illumina launched its Connected Insights cloud-based program in March 2023 to streamline clinical NGS data processing. As interest in genomic research and personalized medicine grows, DNA sequencing emerges as an indispensable tool in healthcare, paving the way for promising advancements in diagnostics, therapeutic strategies, and disease prevention.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dna Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dna Sequencing Market Segmental Analysis

Global DNA Sequencing Market is segmented by Product & Service, Technology, Workflow, Application, End-use and region. Based on Product & Service, the market is segmented into Consumables, Instruments, Services. Based on Technology, the market is segmented into Sanger Sequencing, Next-Generation Sequencing, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing, Third Generation Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing. Based on Workflow, the market is segmented into Grade. Based on Application, the market is segmented into Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Others. Based on End-use, the market is segmented into Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dna Sequencing Market

The primary catalyst propelling the DNA sequencing market is the increasing emphasis on personalized therapy. As modern healthcare shifts towards customized treatments, comprehensive genetic information becomes essential. DNA sequencing enables healthcare providers to tailor therapies to individual genetic profiles, enhancing treatment effectiveness while minimizing adverse effects. This demand is particularly pronounced in the oncology field, where precision medicine relies on genetic insights to inform targeted therapies. The rising application of genomics in clinical practices fuels market growth as healthcare systems prioritize precision medicine to improve patient outcomes, thereby driving the need for advanced sequencing technologies and services.

Restraints in the Global Dna Sequencing Market

The global DNA sequencing market is hindered by several constraints, primarily involving the significant costs associated with infrastructure and resource requirements. Despite a general decline in sequencing costs over time, many research institutions and healthcare providers, particularly in underdeveloped nations, encounter substantial challenges in acquiring the essential reagents, advanced equipment, and skilled personnel needed for effective sequencing operations. Moreover, the financial burden of data processing and storage can further escalate operational expenses. These economic limitations often restrict the implementation of cutting-edge sequencing technologies, particularly within smaller laboratories or facilities, thereby adversely affecting industry growth and limiting access to advanced genomic solutions.

Market Trends of the Global Dna Sequencing Market

The Global DNA Sequencing market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML) technologies, focusing on enhancing data analysis and interpretation capabilities. These advanced algorithms are poised to accelerate genomic data processing, allowing researchers to extract valuable insights from complex datasets with unprecedented speed and accuracy. This shift is particularly impactful in personalized medicine and clinical diagnostics, where the demand for swift and precise genetic information is growing. As AI and ML continue to evolve, they are expected to drive innovation in DNA sequencing applications, ultimately transforming healthcare into a more data-driven landscape that caters to individualized patient needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis

Global DNA Sequencing Market Size by Product & Service & CAGR (2024-2031)

• Market Overview
• Consumables
• Instruments
• Services

Global DNA Sequencing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Sanger Sequencing
• Next-Generation Sequencing
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Targeted Sequencing & Resequencing
• Third Generation Sequencing
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing

Global DNA Sequencing Market Size by Workflow & CAGR (2024-2031)

• Market Overview
• Pre-sequencing
• Sequencing
• Data Analysis

Global DNA Sequencing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Consumer Genomics
• Others

Global DNA Sequencing Market Size by End-use & CAGR (2024-2031)

• Market Overview
• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other Users

Global DNA Sequencing Market Size & CAGR (2024-2031)

• North America, (Product & Service, Technology, Workflow, Application, End-use)
  • US
  • Canada
• Europe, (Product & Service, Technology, Workflow, Application, End-use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product & Service, Technology, Workflow, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product & Service, Technology, Workflow, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product & Service, Technology, Workflow, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences (PacBio)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Element Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MGI (BGI Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OncoDNA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNASTAR
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins GATC Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wasatch BioLabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies (IDT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatic AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation